iphepha

China Manufacturer Auto Khubaza Isirinji ngeNaliti

Inkcazelo emfutshane:

1. Ubungakanani: 0.05ml, 0.1ml, 0.5ml, 1ml, 2ml, 3ml, 5ml, 10ml ekhoyo
2. Iimpawu: i-plunger iya kuphuka i-destoried ukuba inaliti egqityiweyo
3. Ubungakanani benaliti: njengemfuno yomthengi

Iinkcukacha zeMveliso

Iithegi zeMveliso

Intshayelelo

Cima ngokuzenzekela umsebenzi wesirinji:Isebenza ngokuzenzekelayo ekusetyenzisweni kwethamo elimiselweyo elicetywayo ukuthintela ukusetyenziswa kwakhona okulandelayo kwesirinji kunye nenaliti.

K1Cima ngokuzenzekela isitofu kugonyo lwedosi esisigxina
Ubungakanani 0.05ml, 0.1ml, 0.5ml, 1ml, 2ml, 3ml, 5ml, 10ml ekhoyo
Izinto eziphathekayo Ibakala lezonyango pp
Isatifikethi CE/ ISO13485
Iphakheji 1): Iphakheji ye-blister / pc, i-100pcs / ibhokisi, iphakheji yebhokisi
2): Ukupakisha ngobuninzi njengemfuno yomthengi
Noozle 1): 0.05ml , 0.1ml, 0.5ml enenaliti esisigxina
2): 1ml, 2ml, 3ml, 5ml, 10ml luer slip okanye luer lock
Uphawu Emva kwenaliti egqityiweyo, xa utsala umva iplunger, iya kutshixwa ngokuzenzekelayo, iplunger iya kutshatyalaliswa, ikhuseleke kakuhle kwisirinji ephinda isetyenziswe kunye nokwenzakala kwinaliti.
Umgangatho 1): 0.05ml, 0.1ml, 0.5ml : ISO 7886-3
2): 1ml, 2ml, 3ml, 5ml, 10ml: ISO 7886-4

Uyilo lwesirinji ye-LINGYANG ye-AD bubuchwepheshe obulula obusebenzayo yi-Star Syringe Limitd (UK).

Ukulandela inaliti i-plunger iyatshixa kwaye ivale ngokuzenzekelayo ukukhupha isirinji ukuba ingasetyenziswa.

Njengovulindlela womvelisi weesirinji ze-AD eChina, uLingyang unamava atyebileyo kwisirinji ye-AD.

Ngo-2001, uLingyang wafumana iSiqinisekiso soBhaliso sokuqala saseTshayina seesirinji ezingasebenziyo ezizikhubaza ngokuzenzekelayo.

Ngo-2002, uLingyang wadweliswa yi-WHO njengokuphela komboneleli weesirinji ezisebenza ngokuzenzekelayo e-China.

Ngo-2005, sayila kunye nenkampani ye-BD yomgangatho woshishino wesirinji zokuzikhubaza ngokuzenzekelayo kugonyo lwedosi esisigxina-Icandelo lesi-3 leesirinji ze-hypodermic eziSebenzisiweyo zokusetyenziswa kanye.

 

                              




  • Ngaphambili:
  • Okulandelayo: